Abstract
Introduction: Drug resistance has been a continuous challenge in cancer treatment. The use of nanotechnology in the development of new cancer drugs has potential. One of the extensively studied compounds is thymoquinone (TQ), and this work aims to compare two types of TQ-nanoformulation and its cytotoxicity toward resistant breast cancer cells.
Method: TQ-nanoparticles were prepared and optimized by using two different formulations with different drugs to PLGA-PEG ratio (1:20 and 1:7) and different PLGA-PEG to Pluronic F68 ratio (10:1 and 2:1). The morphology and size were determined using TEM and DLS. Characterization of particles was done using UV-VIS, ATR-IR, entrapment efficiency, and drug release. The effects of drug, polymer, and surfactants were compared between the two formulations. Cytotoxicity assay was performed using MTS assay.
Results: TEM finding showed 96% of particles produced with 1:7 drug to PLGA-PEG were less than 90 nm in size and spherical in shape. This was confirmed with DLS which showed smaller particle size than those formed with 1:20 drug to PLGA-PEG ratio. Further analysis showed zeta potential was negatively charged which could facilitate cellular uptake as reported previously. In addition, PDI value was less than 0.1 in both formulations indicating monodispersed and less broad in size distribution. The absorption peak of PLGA-PEG-TQ-Nps was at 255 nm. The 1:7 drug to polymer formulation was selected for further analysis where the entrapment efficiency was 79.9% and in vitro drug release showed a maximum release of TQ of 50%. Cytotoxicity result showed IC50 of TQ-nanoparticle at 20.05 μM and free TQ was 8.25 μM.
Conclusion: This study showed that nanoparticle synthesized with 1:7 drug to PLGA-PEG ratio and 2:1 PLGA-PEG to Pluronic F68 formed nanoparticles with less than 100 nm and had spherical shape as confirmed with DLS. This could facilitate its transportation and absorption to reach its target. There was conserved TQ stability as exhibited slow release of this volatile oil. The TQ-nanoparticles showed selective cytotoxic effect toward UACC 732 cells compared to MCF-7 breast cancer cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ATR-IR:
-
Attenuated Total Reflectance-Infrared Spectroscopy
- DLS:
-
Dynamic Light Scattering
- EE:
-
Entrapment Efficiancy
- ER:
-
estrogen receptor
- HER2:
-
Human Epidermal Growth Factor Receptor 2
- IC50:
-
Half maximal inhibitory concentration
- MDR1:
-
Multidrug Resistance Protein 1
- MRP4:
-
Multidrug Resistance-associated Protein 4
- MTS:
-
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
- PDI:
-
Polydispersity Index
- RPMI:
-
Roswell Park Memorial Institute
- TEM:
-
Transmission Electron Microscope
- TQ:
-
thymoquinone
- UV-VIS:
-
Ultraviolet-visible spectrophotometry
- β-actin:
-
beta actin
References
Alam, S., Khan, Z. I., Mustafa, G., Kumar, M., Islam, F., Bhatnagar, A., & Ahmad, F. J. (2012). Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: A pharmacoscintigraphic study. International Journal of Nanomedicine, 7, 5705–5718.
Anderson, J. M., & Shive, M. S. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews, 28, 5–24.
Astete, C. E., & Sabliov, C. M. (2006). Synthesis and characterization of PLGA nanoparticles. Journal of Biomaterials Science, Polymer Edition, 17(3), 247–289.
Attwood, A. T. F. a. D. (2011). Physicochemical principles of pharmacy. London: Pharmaceutical Pres.
Badary, O. A., Taha, R. A., Gamal El-Din, A. M., & Abdel-Wahab, M. H. (2003). Thymoquinone is a potent superoxide anion scavenger. Drug and Chemical Toxicology, 26(2), 87–98.
Bala, I., Hariharan, S., & Kumar, M. R. (2004). PLGA nanoparticles in drug delivery: The state of the art. Critical Reviews™ in Therapeutic Drug Carrier Systems, 21(5), 387–422.
Bertrand, N., & Leroux, J.-C. (2012). The journey of a drug-carrier in the body: An anatomo-physiological perspective. Journal of Controlled Release, 161(2), 152–163.
Bhattacharya, S., Ahir, M., Patra, P., Mukherjee, S., Ghosh, S., Mazumdar, M., et al. (2015). PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a. Biomaterials, 51, 91–107.
Boudad, H., Legrand, P., Appel, M., Coconnier, M.-H., & Ponchel, G. (2001). Formulation and cytotoxicity of combined cyclodextrin poly (alkylcyanoacrylate) nanoparticles on Caco-2 cells monolayers intended for oral administration of saquinavir. STP Pharma Sciences, 11(5), 369–375.
Burits, M., & Bucar, F. (2000). Antioxidant activity of Nigella sativa essential oil. Phytotherapy Research, 14(5), 323–328.
Cao, L.-B., Zeng, S., & Zhao, W. (2016). Highly stable PEGylated poly (lactic-co-glycolic acid)(PLGA) nanoparticles for the effective delivery of docetaxel in prostate cancers. Nanoscale Research Letters, 11(1), 305.
Chan, J. M., Zhang, L., Yuet, K. P., Liao, G., Rhee, J.-W., Langer, R., & Farokhzad, O. C. (2009). PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery. Biomaterials, 30(8), 1627–1634.
Chau, Y. (2005). Targeted drug delivery by novel polymer-drug conjugates containing linkers cleavable by disease-associated enzymes. Massachusetts Institute of Technology.
Clogston, J. D., & Patri, A. K. (2011). Zeta potential measurement. In Characterization of nanoparticles intended for drug delivery (pp. 63–70). New York: Humana Press.
Coley, H. M. (2004). Development of drug-resistant models. In Cancer cell culture: Methods and protocols (pp. 267–273). Totowa: Humana Press.
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997). The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharmaceutical Research, 14(11), 1568–1573.
El Gazzar, M., El Mezayen, R., Marecki, J. C., Nicolls, M. R., Canastar, A., & Dreskin, S. C. (2006). Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. International Immunopharmacology, 6(7), 1135–1142.
Gali-Muhtasib, H., Ocker, M., Kuester, D., Krueger, S., El-Hajj, Z., Diestel, A., et al. (2008). Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. Journal of Cellular and Molecular Medicine, 12(1), 330–342.
Hajhashemi, V., Ghannadi, A., & Jafarabadi, H. (2004). Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytotherapy Research, 18(3), 195–199.
Hans, M., & Lowman, A. (2002). Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State and Materials Science, 6(4), 319–327.
Holzapfel, V., Musyanovych, A., Landfester, K., Lorenz, M. R., & Mailänder, V. (2005). Preparation of fluorescent carboxyl and amino functionalized polystyrene particles by miniemulsion polymerization as markers for cells. Macromolecular Chemistry and Physics, 206(24), 2440–2449.
Hunter, R. J. (2013). Zeta potential in colloid science: Principles and applications (Vol. 2). Academic. Information, N. f. B. Thymoquinone CID=10281. Retrieved from https://pubchem.ncbi.nlm.nih.gov/compound/10281. Accessed 25 Aug 2017
Ivankovic, S., Stojkovic, R., Jukic, M., Milos, M., Milos, M., & Jurin, M. (2006). The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo. Experimental Oncology, 28(3), 220–224.
Kalimuthu, K., Babu, R. S., Venkataraman, D., Bilal, M., & Gurunathan, S. (2008). Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids and Surfaces B: Biointerfaces, 65(1), 150–153.
Kalishwaralal, K., Banumathi, E., Pandian, S. R. K., Deepak, V., Muniyandi, J., Eom, S. H., & Gurunathan, S. (2009). Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids and Surfaces B: Biointerfaces, 73(1), 51–57.
Karimian, H., & Babaluo, A. (2007). Halos mechanism in stabilizing of colloidal suspensions: Nanoparticle weight fraction and pH effects. Journal of the European Ceramic Society, 27(1), 19–25.
Kreuter, J. (1991). Peroral administration of nanoparticles. Advanced Drug Delivery Reviews, 7(1), 71–86.
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and Surfaces B: Biointerfaces, 75(1), 1–18.
Kurman, R. J. (2013). Blaustein’s pathology of the female genital tract. Boston: Springer Science & Business Media.
Lin, G., Cosimbescu, L., Karin, N. J., & Tarasevich, B. J. (2012). Injectable and thermosensitive PLGA-g-PEG hydrogels containing hydroxyapatite: Preparation, characterization and in vitro release behavior. Biomedical Materials, 7(2), 024107.
Lin, Z., Zhou, D., Hoag, S., & Qiu, Y. (2016). Influence of drug properties and formulation on in vitro drug release and biowaiver regulation of oral extended release dosage forms. The AAPS Journal, 18(2), 333–345.
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009). Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Review of Molecular Diagnostics, 9(4), 325–341.
Maghraby, G. M., & Alomrani, A. H. (2009). Synergistic enhancement of itraconazole dissolution by ternary system formation with pluronic F68 and hydroxypropylmethylcellulose. Scientia Pharmaceutica, 77(2), 401–418.
Makadia, H. K., & Siegel, S. J. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymer, 3(3), 1377–1397.
Nallamuthu, I., Parthasarathi, A., & Khanum, F. (2013). Thymoquinone-loaded PLGA nanoparticles: Antioxidant and anti-microbial properties. International Current Pharmaceutical Journal, 2(12), 202–207.
Odeh, F., Ismail, S. I., Abu-Dahab, R., Mahmoud, I. S., & Al Bawab, A. (2012). Thymoquinone in liposomes: A study of loading efficiency and biological activity towards breast cancer. Drug Delivery, 19(8), 371–377.
Patil, S., Sandberg, A., Heckert, E., Self, W., & Seal, S. (2007). Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials, 28(31), 4600–4607.
Ravindran, J., Nair, H. B., Sung, B., Prasad, S., Tekmal, R. R., & Aggarwal, B. B. (2010). Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. Biochemical Pharmacology, 79(11), 1640–1647. https://doi.org/10.1016/j.bcp.2010.01.023.
Sethi, G., Ahn, K. S., & Aggarwal, B. B. (2008). Targeting nuclear factor-kappa B activation pathway by thymoquinone: Role in suppression of antiapoptotic gene products and enhancement of apoptosis. Molecular Cancer Research, 6, 1059–1070.
Shaarani, S., Hamid, S. S., & Kaus, N. H. M. (2017). The influence of pluronic F68 and F127 nanocarrier on physicochemical properties, in vitro release, and antiproliferative activity of thymoquinone drug. Pharmacognosy Research, 9(1), 12.
Vega, E., Egea, M. A., Garduno-Ramirez, M. L., Garcia, M. L., Sanchez, E., Espina, M., & Calpena, A. C. (2013). Flurbiprofen PLGA-PEG nanospheres: Role of hydroxy-beta-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy. Colloids and Surfaces. B, Biointerfaces, 110, 339–346. https://doi.org/10.1016/j.colsurfb.2013.04.045.
Vuorelaa, P., Leinonenb, M., Saikkuc, P., Tammelaa, P., Rauhad, J. P., Wennberge, T., & Vuorela, H. (2004). Natural products in the process of finding new drug candidates. Current Medicinal Chemistry, 11, 1375–1389.
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012). Nanoparticle delivery of cancer drugs. Annual Review of Medicine, 63, 185–198.
Win, K. Y., & Feng, S.-S. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26(15), 2713–2722.
Yi, T., Cho, S.-G., Yi, Z., Pang, X., Rodriguez, M., Wang, Y., et al. (2008). Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Molecular Cancer Therapeutics, 7(7), 1789–1796.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this paper
Cite this paper
Ahmad, R., Kaus, N.H.M., Hamid, S. (2018). Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells. In: Pham, P.V. (eds) Cancer Biology and Advances in Treatment. Advances in Experimental Medicine and Biology(), vol 1292. Springer, Cham. https://doi.org/10.1007/5584_2018_302
Download citation
DOI: https://doi.org/10.1007/5584_2018_302
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57253-2
Online ISBN: 978-3-030-57254-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)